TOTAL              631
the                      27 
in                       22 
of                       21 
a                        18 
and                      18 
draxis                   13 
to                       13 
that                     13 
is                       11 
jubilant                  9 
for                       8 
's                        8 
it                        8 
company                   7 
business                  7 
with                      7 
its                       6 
has                       5 
by                        5 
said                      5 
manufacturing             5 
be                        4 
an                        4 
indian                    4 
their                     4 
was                       4 
contract                  4 
were                      4 
India                     3 
offering                  3 
per                       3 
share                     3 
canadian                  3 
companies                 3 
potential                 3 
this                      3 
below                     3 
could                     3 
we                        3 
Hectorol                  3 
than                      3 
inc.                      2 
deal                      2 
organosys                 2 
drug                      2 
Friday                    2 
takeover                  2 
grow                      2 
last_year                 2 
also                      2 
acquisition               2 
TSX                       2 
represents                2 
price                     2 
generic                   2 
cardiolite                2 
nuclear                   2 
medicine                  2 
buyer                     2 
opportunity               2 
entry                     2 
into                      2 
attractive                2 
high                      2 
one                       2 
management                2 
employees                 2 
new                       2 
pharmaceutical            2 
involved                  2 
development               2 
two                       2 
offer                     2 
target                    2 
but                       2 
they                      2 
analyst                   2 
wrote                     2 
about                     2 
parts                     2 
while                     2 
believe                   2 
lower                     2 
what                      2 
bid                       2 
trading                   2 
shares                    2 
health                    1 
struck                    1 
us$255-million            1 
friendly                  1 
taken_over                1 
ltd.                      1 
publicly                  1 
traded                    1 
from                      1 
us$6                      1 
producer                  1 
announced                 1 
second                    1 
well-known                1 
firm                      1 
as                        1 
corporations              1 
fast-growing              1 
economy                   1 
flex                      1 
expansion_muscles         1 
look                      1 
beyond                    1 
Asia                      1 
international             1 
Algoma_Steel              1 
bought                    1 
essar                     1 
steel                     1 
$1.85_billion             1 
continuing                1 
wave                      1 
consolidation             1 
left                      1 
steel_sector              1 
foreign                   1 
hands                     1 
have                      1 
been                      1 
examining                 1 
whether                   1 
invest                    1 
oilsands                  1 
properties                1 
northern_Alberta          1 
proposed                  1 
dax                       1 
22.4_per_cent             1 
premium                   1 
over                      1 
Thursday                  1 
closing                   1 
which                     1 
version                   1 
commonly                  1 
used                      1 
imaging                   1 
had                       1 
acknowledged              1 
last_month                1 
talks                     1 
unique                    1 
North                     1 
american                  1 
market                    1 
regulated                 1 
growth                    1 
margin                    1 
radiopharmaceutical       1 
shyam                     1 
Bhartia                   1 
chairman                  1 
managing_director         1 
release                   1 
enables                   1 
consolidate               1 
position                  1 
sterile                   1 
non-sterile               1 
will                      1 
become                    1 
leading                   1 
providers                 1 
small                     1 
volume                    1 
parenterals               1 
large                     1 
pharmaceuticals           1 
biotech                   1 
north_America             1 
excellent                 1 
regulatory                1 
track_record              1 
having                    1 
wealth                    1 
experience                1 
expertise                 1 
radiopharmaceuticals      1 
committed                 1 
supporting                1 
through                   1 
product                   1 
launches                  1 
markets                   1 
expansion                 1 
customer_base             1 
integrated                1 
research                  1 
in_addition_to            1 
several                   1 
locations                 1 
States_in_Maryland        1 
Washington_state          1 
board_of_directors        1 
recommending              1 
shareholders              1 
accept                    1 
analysts                  1 
quick                     1 
say                       1 
somewhat                  1 
prices                    1 
saw                       1 
good                      1 
fit                       1 
between                   1 
Desjardins                1 
securities                1 
Maher_Yaghi               1 
his                       1 
calculations              1 
valued                    1 
at                        1 
us$6.60                   1 
if                        1 
various                   1 
considered                1 
separately                1 
nine                      1 
per_cent                  1 
our                       1 
assessed                  1 
takeout                   1 
valuation                 1 
provides                  1 
fair                      1 
value                     1 
current                   1 
investors                 1 
regardless                1 
given                     1 
risks                     1 
approval                  1 
launch                    1 
sestamibi                 1 
U.S.                      1 
volatility                1 
Draxis_Pharma             1 
base                      1 
considering               1 
possible                  1 
phase-out                 1 
2009                      1 
currently                 1 
greatest                  1 
revenue                   1 
contributor               1 
used_to                   1 
treat                     1 
patients                  1 
kidney_disease            1 
most                      1 
recent                    1 
financial                 1 
report                    1 
production                1 
volumes                   1 
$9_million                1 
2006                      1 
significantly             1 
originally                1 
forecasted                1 
2007                      1 
yaghi                     1 
opt_out                   1 
agreement                 1 
after                     1 
paying                    1 
break                     1 
fee                       1 
us$10.5                   1 
million                   1 
unlikely                  1 
another                   1 
would                     1 
emerge                    1 
immediately               1 
provide                   1 
superior                  1 
counter                   1 
Doug_Loe                  1 
Versant                   1 
partners                  1 
broker                    1 
year                      1 
$7.50                     1 
Toronto                   1 
know                      1 
point                     1 
looks                     1 
as_though                 1 
drugs                     1 
services                  1 
industrial                1 
chemicals                 1 
conglomerate              1 
effectively               1 
integrate                 1 
capabilities              1 
Loe                       1 
these                     1 
are                       1 
areas                     1 
seem                      1 
underdeveloped            1 
in_comparison_to          1 
other                     1 
today                     1 
on                        1 
rose                      1 
$1.01                     1 
$5.95                     1 
gain                      1 
20.5_per_cent             1 
more                      1 
822,000                   1 
